Elanco Animal Health (ELAN) Shares Outstanding (Diluted Average) (2017 - 2026)

Elanco Animal Health has disclosed Shares Outstanding (Diluted Average) across 10 years of filings, most recently posting $506.0 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $506.0 million, up 1.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $506.0 million (up 1.38% YoY), and the FY2025 annual result was $496.4 million, changed 0.18% from the prior year.
• Shares Outstanding (Diluted Average) came in at $506.0 million for Q1 2026 at Elanco Animal Health, up from $496.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $506.0 million in Q1 2026 to a low of $488.3 million in Q4 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $493.7 million (2024), against an average of $494.7 million.
• Across the five-year window, Shares Outstanding (Diluted Average) retreated 0.18% in 2025 and grew 1.38% in 2026, its largest moves.
• Elanco Animal Health's Shares Outstanding (Diluted Average) stood at $488.3 million in 2022, then gained by 0.82% to $492.3 million in 2023, then advanced by 1.02% to $497.3 million in 2024, then declined by 0.18% to $496.4 million in 2025, then increased by 1.93% to $506.0 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $506.0 million (Q1 2026), $496.4 million (Q4 2025), and $496.8 million (Q3 2025), per Business Quant data.